Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
1,96 USD | +10,73% | +2,08% | -52,71% |
14/05 | LEAP THERAPEUTICS, INC. : giudizio positivo da HC Wainwright | ZM |
13/05 | Leap Therapeutics, Inc. riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024 | CI |
Attività
Numero di dipendenti: 54
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Doug Onsi
CEO | Chief Executive Officer | 55 | 01/01/11 |
Chris Mirabelli
CHM | Chairman | 69 | 01/01/11 |
Jason Baum
CTO | Chief Tech/Sci/R&D Officer | 45 | 24/08/20 |
Michael Haas
CTO | Chief Tech/Sci/R&D Officer | - | - |
Cynthia Sirard
CTO | Chief Tech/Sci/R&D Officer | 54 | 01/01/12 |
Augustine Lawlor
COO | Chief Operating Officer | 67 | 01/01/16 |
General Counsel | 56 | 24/08/20 | |
Jonathan Miller
PRN | Corporate Officer/Principal | - | 01/01/20 |
Mark O’Mahony
PRN | Corporate Officer/Principal | 53 | 01/01/11 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Joseph Loscalzo
BRD | Director/Board Member | 72 | 01/01/16 |
Nissim Mashiach
BRD | Director/Board Member | 63 | 01/01/17 |
Chris Mirabelli
CHM | Chairman | 69 | 01/01/11 |
James Cavanaugh
BRD | Director/Board Member | 87 | 01/01/16 |
Thomas Dietz
BRD | Director/Board Member | 60 | 01/01/16 |
Doug Onsi
CEO | Chief Executive Officer | 55 | 01/01/11 |
Chris Richard
BRD | Director/Board Member | 54 | 17/01/23 |
Patricia Martin
BRD | Director/Board Member | 63 | 01/01/23 |
Richard Schilsky
BRD | Director/Board Member | 73 | 01/09/22 |
William Li
BRD | Director/Board Member | 61 | 01/01/17 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 38 264 518 | 32 856 169 ( 85,87 %) | 54 ( 0,000141 %) | 85,87 % |
Coordinate società
Leap Therapeutics, Inc.
47 Thorndike Street Suite B1-1
02141, Cambridge
+617 714 0360
http://www.leaptx.comSettore
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
-52,71% | 75 Mln | |
+15,20% | 121 Mrd | |
+19,67% | 113 Mrd | |
+18,95% | 26,02 Mrd | |
-23,86% | 19,39 Mrd | |
-19,03% | 15,91 Mrd | |
-20,90% | 15,09 Mrd | |
-46,14% | 15,06 Mrd | |
+63,85% | 14,93 Mrd | |
+4,49% | 13,85 Mrd |
- Borsa valori
- Azioni
- Azione LPTX
- Società Leap Therapeutics, Inc.